Biocon Pharma gets GMP compliance certificate from UK's health regulator MHRA for Bengaluru facility
The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection
Representational image. AFP
New Delhi: Biotechnology firm Biocon on Monday said its subsidiary Biocon Pharma has received Good Manufacturing Practice (GMP) compliance certificate from UK's health regulator MHRA for its Bengaluru facility.
"Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received a certificate of Good Manufacturing Practice (GMP) compliance from the Medicines and Healthcare products Regulatory Agency (MHRA), the United Kingdom (UK), for its manufacturing facility at Biocon Park in Bengaluru," Biocon said in a regulatory filing.
The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection in the week of 22 March, 2021, in the wake of travel restrictions amidst COVID-19
, the company added.
Shares of Biocon were trading 0.08 percent lower at Rs 419.95 apiece on BSE.
also read
Sun Pharma's antiepileptic drug approval overturned by USFDA over non-compliance of Halol unit
The company had earlier received a final approval from USFDA in March 2015 for this product
US FDA issues warning letter to Wockhardt’s Ankleshwar plant
US FDA has already banned import of products from the facility into the US market since 5 August 2016
Why a Credit Suisse note has made Sun Pharma shoot up 6% in trade today
Sun Pharmaceutical Industries gained more than 6 percent today, heading towards its biggest single-day gain since April 9 after brokerage Credit Suisse said the pharma major has received a Form 483 from the US FDA on a Gujarat facility.<br />